Paper6488136
Preoperative radiation therapy for locally advanced vulvar cancer.
Hacker NF and 3 others. Cancer, 1984. Cited by 80 papers, by iCite.
Cite this record
ConductScience Library. Preoperative radiation therapy for locally advanced vulvar cancer. Papers, record 6488136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6488136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Vulvar Neoplasms | Major topic |
| Adenocarcinoma | |
| Adult | |
| Aged | |
| Carcinoma, Squamous Cell | |
| Combined Modality Therapy | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Lymphatic Metastasis | |
| Middle Aged | |
| Neoplasm Invasiveness | |
| Radiotherapy Dosage |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40735881 | Cancer of the vulva: 2025 update: FIGO Cancer Report 2025. | Int J Gynaecol Obstet | 2025 | https://conductscience.org/library/papers/40735881 | PubMed |
| 37895358 | The Therapy of Vulvar Carcinoma-Evaluation of Surgical Options in a Retrospective Monocentric Study. | Life (Basel) | 2023 | https://conductscience.org/library/papers/37895358 | PubMed |
| 37752494 | Factors associated with vulvar cancer from 2005 to 2021 in Togo, sub-Saharan Africa. | BMC Womens Health | 2023 | https://conductscience.org/library/papers/37752494 | PubMed |
| 35565394 | Vulvar Cancer: 2021 Revised FIGO Staging System and the Role of Imaging. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35565394 | PubMed |
| 35008331 | Management of Advanced Squamous Cell Carcinoma of the Vulva. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/35008331 | PubMed |
| 34669204 | Cancer of the vulva: 2021 update. | Int J Gynaecol Obstet | 2021 | https://conductscience.org/library/papers/34669204 | PubMed |
| 25848321 | Vulvar cancer: epidemiology, clinical presentation, and management options. | Int J Womens Health | 2015 | https://conductscience.org/library/papers/25848321 | PubMed |
| 24672200 | Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study. | J Midlife Health | 2014 | https://conductscience.org/library/papers/24672200 | PubMed |
| 23205089 | Neoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva. | Oncol Lett | 2012 | https://conductscience.org/library/papers/23205089 | PubMed |
| 21491387 | Chemoradiation for advanced primary vulval cancer. | Cochrane Database Syst Rev | 2011 | https://conductscience.org/library/papers/21491387 | PubMed |
| 14990203 | Carcinoma of the vulva: combined modality treatment. | Curr Treat Options Oncol | 2004 | https://conductscience.org/library/papers/14990203 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6488136
GET https://conductscience.org/api/papers/v1/6488136/authors